Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer.
Jacob J, Anami Y, High P, Liang Z, Subramanian S, Ghosh SC, AghaAmiri S, Guernsey-Biddle C, Tran H, Rowe JH, Azhdarinia A, Tsuchikama K, Carmon KS.
Jacob J, et al. Among authors: tsuchikama k.
bioRxiv [Preprint]. 2024 Nov 21:2024.02.20.581056. doi: 10.1101/2024.02.20.581056.
bioRxiv. 2024.
PMID: 39605519
Free PMC article.
Updated.
Preprint.